Evaluación neuropsicológica y provisión de apoyos en la enfermedad mental

  1. Mª del Carmen García Pérez
  2. Cristina Jenaro Río
  3. Noelia Flores Robaina
Revue:
International Journal of Developmental and Educational Psychology: INFAD. Revista de Psicología

ISSN: 0214-9877

Année de publication: 2013

Titre de la publication: Familia y Educación: Aspectos Positivos

Volumen: 1

Número: 1

Pages: 57-65

Type: Article

DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: International Journal of Developmental and Educational Psychology: INFAD. Revista de Psicología

Résumé

We present the results obtained after assessing the psychological functioning of 150 partici- pants with severe and prolonged mental illness. For the assessment we utilized the Luria-DNA Battery and the Wechsler Scale for the Assessment of Adult Intelligence (WAIS). Specifically, we aim to: (1) provide data on the concurrent validity of the Luria-DNA battery through the study of corre- lations between the battery and the WAIS. (2) Analyze the impact of clinical variables in the psy- chological performance of these patients, (3) obtain a neuropsychological performance profile. The results support the reliability and validity of the battery and its usefulness in neuropsychological assessment of patients with schizophrenia. The results obtained allow us to offer suggestions to improve the provision of supports

Références bibliographiques

  • Baeder DH. (2001). An examination of the neuropsychological utility of the WAIS-III. Dissertation Abstracts International: The Sciences and Engineering, 61(8-B): : 4469.
  • Bausela, E. y Orozco, C.I. (2009). Estudio piloto de validación de la batería neuropsicológica luria- inicial con el subtest de matrices del WISC-IV y el test de matrices progresivas de Raven. Boletín Electrónico de Investigación de la Asociación Oaxaqueña de Psicología, 5(1): 57-66.
  • Blyler, C. R., Gold, J. M., Iannone, V. N., y Buchanan, R. W. (2000). Short form of the WAIS-III for use with patients with schizophrenia. Schizophrenia Research, 46(2-3), 209-215
  • Chen, H., y Yao, S.Q. (2009). A comparison between nonclinical and schizophrenia sample on the results measured by WAIS-III Chinese version. Chinese Journal of Clinical Psychology, 17(2), 157-160.
  • Dickinson, D. (2001). Exploring WAIS-III variables and everyday functioning among individuals with schizophrenia spectrum disorders. Dickinson, Dwight: U Maryland Coll Park, US.
  • Digiacomo, M.R., Gómez, C.M., Gómez, J., Camacho, M. (2006). Contribuciones desde el EEG para la comprensión de la esquizofrenia. Psiquiatría biológica, 13( 4): 136-144.
  • Dikerson, F.B., RIngel, N.B., y Boronow, J.J. (1991). Neuropsychological deficits in chronic schizo- phrenics: Relationship with symptoms and behavior. Journal of Nervous and Mental Disease, 179/12), 744-749.
  • Dura, I. F., Peris, M. R., Vivo, C. D., y Ruiz, J. C. (2010). Short form of the WAIS-III for use with patients with schizophrenia. Psicothema, 22(2), 202-207.
  • Fossati P, Amar G, Raoux N, Ergis AM y Allilaire JF. (1999). Executive functioning and verbal memory in young patients with unipolar depression and schizophrenia. Psychiatry Research, 89: 171-87 profesionales y familiares : tomo II. Valencia: Colegio Oficial de Psicólogos de la Comunidad Valenciana.
  • Goikoetxea, E., Aznar, S., Cortajarena, C., Ponte, J., Ugarte, K., y Uriarte, J. (2001). The WAIS-III in schizophrenic patients: Validity data. Revista de Psicología General y Aplicada, 54(2), 245-257.
  • Gold, J.M., Hermann, B.P., Randolph, C., Wyler, A.R., Golberg, J.E. y Weiberger, D.R. (1994). Schizophrenia and temporal lobe epilepsy: A neuropsychological analysis. Archives of General Psychiatry, 54, 265-272.
  • Golden, C. J., Freshwater, S. M., y Vayalakkara, J. (2000). The Luria Nebraska Neuropsychological Battery Neuropsychological assessment in clinical practice: A guide to test interpretation and integration (pp. 263-289). Hoboken, NJ: John Wiley & Sons Inc; US. 1999). El curso de la esquizofrenia. Diez años de seguimiento retrospectivo. Psiquiatría Pública, 11 (2): 16-21.
  • González-Pardo, H. (2007). Efectividad de los modernos fármacos antipsicóticos en el tratamiento de la esquizofrenia y otros trastornos psicóticos: ¿avance terapéutico o más de lo mismo? Papeles del Psicólogo, 28(2): 111-116
  • Harding CM, Brooks GW, Ashikaga T et al. (1987). The Vermont longitudinal study of persons with severe mental illness. American Journal of Psychiatry, 144 (6): 727-735.
  • Ilonen, T., Taiminen, T., Karlsson, H., Lauerma, H., Leinonen, K. y Wallenius, E (2004). Neuropsychological subtyping of schizophrenia. Psychiatry Research, 129(2): 191-199.
  • Iverson, G. L. (2001). Interpreting change on the WAIS-III/WMS-III in clinical samples. f Archives of Clinical Neuropsychology, 16(2), 183-191.
  • Kaplan, R. M., y Saccuzzo, D. P. (2005). Psychological testing: Principles, applications, and issues. Belmont, CA : Thompson Wadsworth.
  • Manga D. y Ramos, F. (2000). Luria – DNA. Batería Luria de diagnóstico neuropsicológico de adul- tos. Madrid: TEA.
  • Martínez, J.A., Guardia, J. y Peña, J. (1996) Validación de las subpruebas del test Barcelona rela- cionadas con subtests de la escala de inteligencia de Wechsler para adultos. Neuropsychology Latina, 2(1): 10-14.
  • Adult Intelligence Scale–Revised. Ar chives of Clinical Neuropsychology, 12(2): 97-109.
  • Rodríguez, R. H., Romero, C. C., Abolafia, A. A., y Robles, C. C. (2002). Assessment through WAIS III of the cognitive deficit distinctive to schizophrenia: Preliminary findings. Archivos de Psiquiatria, 65(4), 383-392.
  • Schoenberg, M. R., Duff, K., Scott, J. G., y Adams, R. L. (2003). An evaluation of the clinical utility of the OPIE-3 as an estimate of premorbid WAIS-III FSIQ. The Clinical Neuropsychologist, 17(3), 77 308-321
  • Seidman, L.J., Yurgelun-Todd, D., Kremen, W.S., Woods, B.T., Goldsteins, J.M., Faraone, S.V. y Tsuanf, M.T. (1994). Relationship of prefrontal and temporal lobe MRI measures to neuropsu- chological performance in chronic schizophrenia. Biological Psychiatry, 35, 235-246.
  • Seisdedos, N., Corral, S., Cordero, A., de la Cruz, M.V., Hernández, M.V. y Pereña, J. (1999). WAIS- III. Escala de Inteligencia de Wechsler para Adultos-III. Madrid: TEA Ediciones. Shakow, D. (1963). Psychological deficit in schizophrenia. Behavioral Scince, 8 (4): 275-305.
  • Stip, E. (2001). Antipsicóticos nuevos: temas y controversias. Tipicidad de los antipsicóticos atípi- cos. Revista de Psiquiatría del Uruguay, 65(1) : 70-91.
  • Tansella M, Micciolo R, Biggeri A et al. (1995). Episodes of care for first-ever psychiatric patients. British Journal of Psychiatry, 167: 220- 227.
  • Tramontana, M.G, Klee, S.H. y Boyd, T.A. (1984) WISC-R interrelationships with the Halstead – Reitan and Children’s Luria neuropsychological batteries. International Journal of Clinical Neuropsychology, 6(1): 1-8.
  • Verdoux, H., Liraud, F., Bergey, C., Assens, F., Abalan, F. y van Oj. (2001). Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first- admitted patients. Schizophrenia Research, 49(3):231-41.
  • Walker, J., D’Amato, R. C., y Davis, A. S. (2008). Understanding and using the Luria-Nebraska Neuropsychological Test Batteries with children and adults Essentials of neuropsychological assessment: Treatment planning for rehabilitation (2nd ed., pp. 127-148). New York, NY: Springer Publishing Co; US.
  • Wiersma, D., Nienhuis, F.J., Slooff, C.J. y Giel, R. (1998). Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophrenia Bulletin, 24(1):75-85.
  • Wykes, T,. Reeder, C., Landau, S., Everitt, B., Knapp, M., Patel, A. y Romeo, R. (2007) Cognitive remediation therapy in schizophrenia. Randomised controlled trial. The British Journal of Psychiatry, 190, 421-427.
  • Wykes, T., Reeder, C., Corner, J., et al (2003) Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research, 61, 163 -174
La source de données: Dialnet